Decktherapeutics
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Albany, New York, 12207, United StatesWebsite
www.decktherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Decktherapeutics
Deck Therapeutics is focused on pioneering neuroprotection through the development of acute omega-3 fatty acid therapeutics, specifically targeting conditions like neonatal hypoxic-ischemic encephalopathy (HIE) and ischemic stroke. Their lead product, THDG3, is a novel semi-synthetic omega-3 fatty acid glyceride emulsion that has shown superior neuroprotective effects compared to traditional omega-3 triglyceride emulsions. The company aims to address significant unmet medical needs in brain injuries caused by insufficient oxygen supply during labor and delivery, as well as in ischemic stroke. Deck Therapeutics is open to partnerships to leverage its expertise and intellectual property in the field of acute omega-3 therapeutics.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Decktherapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Decktherapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Decktherapeutics recently announced quarterly report
Check out if Decktherapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Decktherapeutics
Funding: Get notified immidiatlly once Decktherapeutics has new funding data
Click to see if Decktherapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Decktherapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Decktherapeutics launches new products
Recommended Actions
Reach out to Masked Content who joined Decktherapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Decktherapeutics
Compare insights from companies similar to Decktherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Decktherapeutics
<$5M
1-10
Private
-
2019
N/A
Company Profile Activity
Activity Insights
Decktherapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Decktherapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Decktherapeutics.
Decktherapeutics Tech Stack
A closer look at the technologies used by Decktherapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Decktherapeutics
Sign Up For FreeTo access detailed company insights
Deck Therapeutics is focused on pioneering neuroprotection through the development of acute omega-3 fatty acid therapeutics, specifically targeting conditions like neonatal hypoxic-ischemic encephalopathy (HIE) and ischemic stroke. Their lead product, THDG3, is a novel semi-synthetic omega-3 fatty acid glyceride emulsion that has shown superior neu... Read More
